SOP on PopPK analysis
From: Ruedi Port r.port@dkfz.de
Subject: [NMusers] SOP on PopPK analysis
Date: Mon, March 22, 2004 11:36 am
Dear colleagues:
This is to make you aware of a Standard Operating Procedure
on PopPK analysis published by the Central European Society
for Anticancer Research (CESAR):
CESAR-EWIV: Standard Operating Procedures for Clinical Trials (SOPs).
SOP 14: Population Pharmacokinetic Analysis.
Onkologie 26 (suppl. 6), 60 - 66, 2003
(.pdf file:
http://content.karger.com/ProdukteDB/produkte.asp?doi=000075017
)
The document covers the basic steps of a population PK analysis
and should be useful to newcomers as a roadmap.
Ruedi
-------------------------------------------------------------------------------
Dr. R.E. Port, German Cancer Research Center, E-120
P.O. Box 10 19 49, D-69009 Heidelberg, Germany
phone: +49-6221 42-3381
fax: -3382
e-mail: r.port@dkfz.de
_______________________________________________________